Zanubrutinib: past, present, and future by Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat

Get full text

Correction: Zanubrutinib: past, present, and future by Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat

Get full text

P1678: INTERVENTIONS AND THERAPY AT END OF LIFE IN HAEMATOLOGICAL MALIGNANCY: A RETROSPECTIVE COHORT STUDY ON HEALTHCARE UTILISATION by Briony Shaw, Catriona Parker, Jake Shortt, Stephen Opat, Peter Poon

Get full text

Disseminated Enteroviral Infection Associated with Obinutuzumab by Claire Dendle, Michael Gilbertson, Tony M. Korman, Vera Golder, Eric Morand, Stephen Opat

Get full text

Efficacy of Zanubrutinib in the Treatment of Bing–Neel Syndrome by Jonathan Wong, Lawrence Cher, James Griffiths, Aileen Cohen, Jane Huang, Lai Wang, Gareth Gregory, Stephen Opat

Get full text

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study by Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat

Get full text

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia by Constantine Tam, Javier Munoz, Gavin Cull, Stephen Opat, Heather Allewelt, Xiaoping Zhang, Jennifer C. Stern, James Hilger, Kunthel By, Aileen Cohen, Alessandra Tedeschi

Get full text

Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy by Hiu Lam Agnes Yuen, Alison Slocombe, Vanessa Heron, Sanjeev Chunilal, Jake Shortt, Maciej Tatarczuch, George Grigoriadis, Sushrut Patil, Gareth P. Gregory, Stephen Opat, Michael Gilbertson

Get full text

Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response t... by Amy Body, Elizabeth Ahern, Luxi Lal, Karen Gillett, Hesham Abdulla, Stephen Opat, Tracey O’Brien, Peter Downie, Stuart Turville, C. Mee Ling Munier, Corey Smith, C. Raina MacIntyre, Eva Segelov

Get full text

Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis by Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu

Get full text

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials by Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Zhiyue Huang, Huafei Lu, Yuqin Song, Yongping Song

Get full text

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes

Get full text

Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes

Get full text

P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEU... by Matko Kalac, Mark Hertzberg, Chan Cheah, Vincent Ribrag, Pablo Abrisquet Acosta, Stephen Opat, Emmanuel Bachy, Loïc Ysebaert, Lihua Qiu, Shuhua Yi, Noriko Nishimura, Charlotte Lemech, Jacqueline Bussolari, Changchun Deng, Tianbao Lu, Liang Xiu, Sandy Van Hemelryck, Ulrike Philippar, Yue Guo, Virginie Soete, Isabel Soriano, Nele Fourneau, John Gerecitano, Franck Morschhauser

Get full text

P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-... by Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim Linton, Pam Mckay, Sophie Leitch, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Teague, Pier Luigi Zinzani, Peter Browett, Catherine Thieblemont, Anna Marina Liberati, Emmanuel Bachy, Federica Cavallo, Régis Costello, Sunil Iyengar, Roberto Marasca, Heidi Mociková, Jin Seok Kim, Dipti Talaulikar, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman

Get full text

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW... by Talha Munir, Mazyar Shadman, Tadeusz Robak, Jennifer R. Brown, Brad Kahl, Paolo Ghia, Krzysztof Giannopoulos, Martin Simkovic, Anders Österberg, Luca Laurenti, Patricia Walker, Stephen Opat, Hanna Ciepluch, Richard Greil, Merit Hanna, Monica Tani, Marek Trneny, Danielle M. Brander, Ian W. Flinn, Sebastian Grosicki, Emma Verner, Alessandra Tedeschi, Sophie De Guibert, Gayane Tumyan, Kamel Laribi, Jose Antonio Garcia Marco, Jianyong LI, Tian Tian, Vanitha Ramakrishnan, Yu Liu, Andy Szeto, Jason Paik, Aileen Cohen, Constantine Tam, Wojciech Jurczak

Get full text